Literature DB >> 16327533

Minimal clinically important difference for the UCSD Shortness of Breath Questionnaire.

David H Kupferberg1, Robert M Kaplan, Donald J Slymen, Andrew L Ries.   

Abstract

PURPOSE: A minimal clinically important difference (MCID) is important in evaluating clinical measures such as health-related quality of life (HRQOL) instruments. The purpose of this analysis is to evaluate MCID for the UCSD Shortness of Breath Questionnaire (SOBQ).
METHODS: We examined measures of disease-specific and generic HRQOL in 164 subjects with chronic lung disease before and after pulmonary rehabilitation. Subjects completed 2 disease-specific [SOBQ, Chronic Respiratory Questionnaire (CRQ)], and 2 generic HRQOL measures [RAND-36 and Quality of Well-Being Scale (QWB)]. The MCID was calculated using 3 methods: effect size, standard error of the measurement (SEM), and comparison between the SOBQ and CRQ Dyspnea scores.
RESULTS: HRQOL measures correlated moderately with measures of maximum exercise tolerance but not with lung function (FEV1, FVC). HRQOL and exercise capacity improved significantly after pulmonary rehabilitation. A change of 5 units for the SOBQ appears to be a reasonable MCID for this instrument. The calculated MCIDs for the CRQ (0.47/item) and QWB (0.031) were consistent with established change scores.
CONCLUSIONS: The MCID calculated using an SEM approach for the SOBQ, CRQ, and QWB meets clinical expectations for these instruments. HRQOL measures provide information that is complementary and distinct from physiological measures.

Entities:  

Mesh:

Year:  2005        PMID: 16327533     DOI: 10.1097/00008483-200511000-00011

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil        ISSN: 0883-9212            Impact factor:   2.081


  33 in total

1.  Perfusion scintigraphy and patient selection for lung volume reduction surgery.

Authors:  Divay Chandra; David A Lipson; Eric A Hoffman; John Hansen-Flaschen; Frank C Sciurba; Malcolm M Decamp; John J Reilly; George R Washko
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

2.  Does roflumilast improve dyspnea in patients with chronic obstructive pulmonary disease? A meta-analysis.

Authors:  Lei Pan; Yong-Zhong Guo; Bo Zhang; Jun-Hong Yan
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

3.  Effect of a Motivational Interviewing-Based Health Coaching on Quality of Life in Subjects With COPD.

Authors:  Hamid Rehman; Craig Karpman; Kristin Vickers Douglas; Roberto P Benzo
Journal:  Respir Care       Date:  2017-06-13       Impact factor: 2.258

4.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

5.  Pulmonary Rehabilitation Improves Outcomes in Chronic Obstructive Pulmonary Disease Independent of Disease Burden.

Authors:  Praful Schroff; Jason Hitchcock; Christopher Schumann; J Michael Wells; Mark T Dransfield; Surya P Bhatt
Journal:  Ann Am Thorac Soc       Date:  2017-01

6.  A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.

Authors:  David A Zisman; Marvin Schwarz; Kevin J Anstrom; Harold R Collard; Kevin R Flaherty; Gary W Hunninghake
Journal:  N Engl J Med       Date:  2010-05-18       Impact factor: 91.245

7.  Coping and quality of life in patients awaiting lung transplantation.

Authors:  Jessica L Taylor; Patrick J Smith; Michael A Babyak; Krista A Barbour; Benson M Hoffman; Deborah L Sebring; R Duane Davis; Scott M Palmer; Francis J Keefe; Robert M Carney; Iris Csik; Kenneth E Freedland; James A Blumenthal
Journal:  J Psychosom Res       Date:  2008-07       Impact factor: 3.006

8.  Long-term Exercise After Pulmonary Rehabilitation (LEAP): Design and rationale of a randomized controlled trial of Tai Chi.

Authors:  Marilyn L Moy; Peter M Wayne; Daniel Litrownik; Douglas Beach; Elizabeth S Klings; Roger B Davis; Gloria Y Yeh
Journal:  Contemp Clin Trials       Date:  2015-09-08       Impact factor: 2.226

9.  Predictors of Mortality Poorly Predict Common Measures of Disease Progression in Idiopathic Pulmonary Fibrosis.

Authors:  Brett Ley; Williamson Z Bradford; Eric Vittinghoff; Derek Weycker; Roland M du Bois; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2016-09-15       Impact factor: 21.405

10.  Randomized placebo controlled assessment of airway inflammation due to racemic albuterol and levalbuterol via exhaled nitric oxide testing.

Authors:  John F Freiler; Rajiv Arora; Thomas C Kelley; Larry Hagan; Patrick F Allan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.